Eli Raveh

1.2k total citations · 1 hit paper
8 papers, 952 citations indexed

About

Eli Raveh is a scholar working on Cancer Research, Molecular Biology and Urology. According to data from OpenAlex, Eli Raveh has authored 8 papers receiving a total of 952 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Cancer Research, 4 papers in Molecular Biology and 2 papers in Urology. Recurrent topics in Eli Raveh's work include Cancer-related molecular mechanisms research (4 papers), RNA modifications and cancer (3 papers) and Hair Growth and Disorders (2 papers). Eli Raveh is often cited by papers focused on Cancer-related molecular mechanisms research (4 papers), RNA modifications and cancer (3 papers) and Hair Growth and Disorders (2 papers). Eli Raveh collaborates with scholars based in Israel, Palestinian Territory and United States. Eli Raveh's co-authors include Michal Gilon, Imad Matouk, Abraham Hochberg, Vladimir Sorin, Avraham Hochberg, Abraham Czerniak, David Halle, Ayala Hubert, Uri Gat and Tatiana Birman and has published in prestigious journals such as International Journal of Molecular Sciences, Molecular Cancer and Biochimica et Biophysica Acta (BBA) - Molecular Cell Research.

In The Last Decade

Eli Raveh

8 papers receiving 948 citations

Hit Papers

The H19 Long non-coding RNA in cancer initiation, progres... 2015 2026 2018 2022 2015 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eli Raveh Israel 8 766 758 97 81 68 8 952
Michal Gilon Israel 9 833 1.1× 848 1.1× 109 1.1× 67 0.8× 78 1.1× 10 1.0k
Robert T. Sweeney United States 11 289 0.4× 305 0.4× 32 0.3× 95 1.2× 51 0.8× 15 519
Keiichi Koshizuka Japan 24 993 1.3× 920 1.2× 19 0.2× 129 1.6× 61 0.9× 37 1.2k
Balaji Muralidhar United Kingdom 11 483 0.6× 369 0.5× 115 1.2× 101 1.2× 222 3.3× 11 755
Claudia Augello Italy 13 368 0.5× 196 0.3× 49 0.5× 83 1.0× 49 0.7× 23 570
Mohamed Riad Egypt 5 216 0.3× 212 0.3× 18 0.2× 170 2.1× 85 1.3× 14 595
Qingfeng Ni China 15 334 0.4× 256 0.3× 49 0.5× 113 1.4× 101 1.5× 32 586
K Bird United Kingdom 9 226 0.3× 106 0.1× 69 0.7× 144 1.8× 78 1.1× 10 464
Koichi Suzuki Japan 18 452 0.6× 288 0.4× 55 0.6× 333 4.1× 113 1.7× 58 853
Ernst Heinmöller Germany 12 292 0.4× 211 0.3× 37 0.4× 275 3.4× 165 2.4× 24 664

Countries citing papers authored by Eli Raveh

Since Specialization
Citations

This map shows the geographic impact of Eli Raveh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Raveh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Raveh more than expected).

Fields of papers citing papers by Eli Raveh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eli Raveh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Raveh. The network helps show where Eli Raveh may publish in the future.

Co-authorship network of co-authors of Eli Raveh

This figure shows the co-authorship network connecting the top 25 collaborators of Eli Raveh. A scholar is included among the top collaborators of Eli Raveh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eli Raveh. Eli Raveh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Lavie, Ofer, David Edelman, Tally Levy, et al.. (2017). A phase 1/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian/peritoneal cancer. Archives of Gynecology and Obstetrics. 295(3). 751–761. 44 indexed citations
2.
Raveh, Eli, Imad Matouk, Michal Gilon, & Abraham Hochberg. (2015). The H19 Long non-coding RNA in cancer initiation, progression and metastasis – a proposed unifying theory. Molecular Cancer. 14(1). 184–184. 428 indexed citations breakdown →
3.
Matouk, Imad, David Halle, Eli Raveh, et al.. (2015). The role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decision. Oncotarget. 7(4). 3748–3765. 107 indexed citations
4.
Matouk, Imad, Eli Raveh, Rasha Abu-lail, et al.. (2014). Oncofetal H19 RNA promotes tumor metastasis. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1843(7). 1414–1426. 203 indexed citations
5.
Matouk, Imad, Eli Raveh, Patricia Ohana, et al.. (2013). The Increasing Complexity of the Oncofetal H19 Gene Locus: Functional Dissection and Therapeutic Intervention. International Journal of Molecular Sciences. 14(2). 4298–4316. 82 indexed citations
6.
Raveh, Eli, et al.. (2008). A chromatin immunoprecipitation screen in mouse keratinocytes reveals Runx1 as a direct transcriptional target of ΔNp63. Journal of Cellular Biochemistry. 104(4). 1204–1219. 20 indexed citations
7.
Raveh, Eli, Shulamit Cohen, Ditsa Levanon, et al.. (2006). Dynamic expression of Runx1 in skin affects hair structure. Mechanisms of Development. 123(11). 842–850. 37 indexed citations
8.
Raveh, Eli, Shulamit Cohen, Ditsa Levanon, Yoram Groner, & Uri Gat. (2005). Runx3 is involved in hair shape determination. Developmental Dynamics. 233(4). 1478–1487. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026